DK2870141T3 - Methanthion-forbindelser med antivirus-aktivitet - Google Patents

Methanthion-forbindelser med antivirus-aktivitet

Info

Publication number
DK2870141T3
DK2870141T3 DK13722781.5T DK13722781T DK2870141T3 DK 2870141 T3 DK2870141 T3 DK 2870141T3 DK 13722781 T DK13722781 T DK 13722781T DK 2870141 T3 DK2870141 T3 DK 2870141T3
Authority
DK
Denmark
Prior art keywords
methanthion
compounds
antivirus activity
compound
formula
Prior art date
Application number
DK13722781.5T
Other languages
Danish (da)
English (en)
Inventor
Mohammed Homman
Robert Berg
Jan Bergman
Ngarita Kingi
Original Assignee
Vironova Influenza Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48444409&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2870141(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vironova Influenza Ab filed Critical Vironova Influenza Ab
Application granted granted Critical
Publication of DK2870141T3 publication Critical patent/DK2870141T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C07D249/061,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK13722781.5T 2012-05-18 2013-05-17 Methanthion-forbindelser med antivirus-aktivitet DK2870141T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261648700P 2012-05-18 2012-05-18
US201261659516P 2012-06-14 2012-06-14
US201261666286P 2012-06-29 2012-06-29
US201361774991P 2013-03-08 2013-03-08
PCT/EP2013/060266 WO2013171334A1 (en) 2012-05-18 2013-05-17 Methanethione compounds having antiviral activity

Publications (1)

Publication Number Publication Date
DK2870141T3 true DK2870141T3 (da) 2018-01-29

Family

ID=48444409

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13722781.5T DK2870141T3 (da) 2012-05-18 2013-05-17 Methanthion-forbindelser med antivirus-aktivitet

Country Status (20)

Country Link
US (1) US9359310B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP2870141B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (2) JP6484168B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR102092207B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN104540810B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU2013261735B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR112014028632B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2879816C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CL (1) CL2014003116A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK2870141T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EA (1) EA029044B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2657942T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL235742A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN2014DN10658A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX356846B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY169094A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ702073A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG (1) SG11201407703QA (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2013171334A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA201409220B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169094A (en) * 2012-05-18 2019-02-18 Vironova Ab Methanethione compounds having antiviral activity
CN107056762B (zh) * 2016-12-22 2020-08-28 四川百利药业有限责任公司 一种用作抗流感病毒的双羰基类似物
WO2021204924A1 (en) 2020-04-09 2021-10-14 Vironova Medical Ab Compounds for use in the treatment of hypercytokinemia
WO2021204923A1 (en) 2020-04-09 2021-10-14 Vironova Medical Ab Antiviral agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642390B2 (en) 2001-07-11 2003-11-04 Lexicon Pharmaceuticals, Inc. One step synthesis of 1,2,3-triazole carboxylic acids
BRPI0407088A (pt) * 2003-01-28 2006-01-24 Aventis Pharma Sa Produtos n-aril-heteroaromáticos, composições contendo os mesmos e seu uso
EP2278879B1 (en) 2008-04-21 2016-06-15 PATH Drug Solutions Compounds, compositions and methods comprising oxadiazole derivatives
MX2012001504A (es) 2009-08-05 2012-06-01 Versitech Ltd Compuestos antivirales y metodos para elaborarlos y usarlos.
CN103209977A (zh) * 2010-09-28 2013-07-17 百时美施贵宝公司 作为广谱抗流感病毒剂的带有取代的杂芳基的新的哌嗪类似物
EP2484655A1 (en) 2011-02-04 2012-08-08 Vironova AB A thionation process and a thionating agent
MY169094A (en) * 2012-05-18 2019-02-18 Vironova Ab Methanethione compounds having antiviral activity
JP6762767B2 (ja) * 2016-06-01 2020-09-30 キヤノン株式会社 撮像素子、撮像装置、および撮像信号処理方法

Also Published As

Publication number Publication date
JP6484168B2 (ja) 2019-03-13
MY169094A (en) 2019-02-18
ES2657942T3 (es) 2018-03-07
NZ702073A (en) 2017-07-28
BR112014028632A8 (pt) 2018-04-03
CA2879816A1 (en) 2013-11-21
AU2013261735B2 (en) 2017-07-20
ZA201409220B (en) 2016-08-31
KR102092207B1 (ko) 2020-03-23
EP2870141B1 (en) 2017-11-22
HK1210165A1 (en) 2016-04-15
JP2018065817A (ja) 2018-04-26
JP2015517516A (ja) 2015-06-22
SG11201407703QA (en) 2015-01-29
BR112014028632A2 (pt) 2017-06-27
BR112014028632B1 (pt) 2020-01-28
AU2013261735A1 (en) 2015-01-22
US9359310B2 (en) 2016-06-07
MX2014014007A (es) 2015-05-11
EA029044B1 (ru) 2018-02-28
EP2870141A1 (en) 2015-05-13
CL2014003116A1 (es) 2015-08-07
KR20150012289A (ko) 2015-02-03
WO2013171334A1 (en) 2013-11-21
CN104540810A (zh) 2015-04-22
US20150133468A1 (en) 2015-05-14
MX356846B (es) 2018-06-18
IN2014DN10658A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2015-08-28
EA201401277A1 (ru) 2015-04-30
CN104540810B (zh) 2017-01-18
CA2879816C (en) 2020-07-07
IL235742A0 (en) 2015-02-01

Similar Documents

Publication Publication Date Title
CR20140231A (es) Derivados de ácido benzotiazol-6-il acético y su uso para tratar una infección por vih
EA201390885A1 (ru) Азаиндолы в качестве противовирусных агентов против респираторного синцитиального вируса
NZ724503A (en) Macrocyclic inhibitors of flaviviridae viruses
PH12014502739A1 (en) Macrocyclic inhibitors of flaviviridae viruses
LT3456721T (lt) Junginių, pasižyminčių živ integrazės inhibavimo aktyvumu, gavimo būdas
UA114087C2 (xx) Похідні піридину
LT2916860T (lt) Diabeto gydymui skirta kompozicija, apimanti oksintomodulino analogą
LT2755473T (lt) Paraziticidinės kompozicijos, apimančios izoksazolino veiklųjį agentą, būdai ir jų panaudojimai
EA201591064A1 (ru) Новые производные пиридина
NZ703066A (en) Macrocyclic inhibitors of flaviviridae viruses
UA116395C2 (uk) ПОХІДНІ ТРИАЗОЛ[4,5-b]ПІРИМІДИНУ
PH12017500048A1 (en) Pyridone derivative having tetrahydropyranylmethyl group
JO3063B1 (ar) مركب مبتكر وطرق لانتاجه
CA2873723A1 (en) Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyrase
EA201490643A1 (ru) Новые производные бетулиновой кислоты с противовирусной активностью
PH12015502118A1 (en) Pyridin-4-yl derivatives
WO2014152716A8 (en) Substituted heterocyclic compounds for treating or preventing viral infections
PH12014502743A1 (en) Carbamate/urea derivatives
UA111333C2 (uk) Спосіб одержання l-аргінінової солі периндроприлу
BR112013005609A2 (pt) composto de fórmula (i), composição, uso de um composto e novos compostos, processos, método e usos
HK1221645A1 (zh) Vmat2的苯並喹啉抑制劑
WO2014116772A3 (en) Squaric derivatives for the treatment of hepatitis c
DK2870141T3 (da) Methanthion-forbindelser med antivirus-aktivitet
DOP2015000007A (es) Métodos para preparar triazolopiridinas sutituidas
MX2013007726A (es) Derivados de 2-metoxi-piridin-4-ilo.